Chembio Diagnostics (NASDAQ:CEMI) Research Coverage Started

StockNews.com started coverage on shares of Chembio Diagnostics (NASDAQ:CEMI – Get Rating) in a report issued on Sunday. The firm issued a hold rating on the stock. Chembio Diagnostics Stock Performance The firm’s 50 day moving average is $0.43 and its two-hundred day moving average is $0.36. Chembio Diagnostics has a fifty-two week low of […]

Related Keywords

, York Mellon Corp , Vanguard Group Inc , Renaissance Technologies , Securities Exchange Commission , Virtu Financial , Chembio Diagnostics Inc , Chembio Diagnostics , Get Rating , Advisors Ll Perceptive , Exchange Commission , New York Mellon Corp , Chembio Diagnostics Daily , Nasdaq Cemi , Acemi , Medical , Initiated Coverage , Stocknews Com ,